CardiologIA: New AI Tools for Enhanced Diagnosis of Cardiovascular Disease

• 
  Tuesday, 4 March 2025
• 
  11:45h - 12:00h
• 
  • 

    Paula Petrone
    Leading Researcher at Life Sciences Department, Barcelona Supercomputing Center (BSC)

• 

  Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, disproportionately affecting low- and middle-income countries. Despite medical advancements, CVD is often misdiagnosed due to complex and varied symptoms, resulting in delayed treatment and adverse outcomes. Artificial intelligence (AI) offers a transformative approach to improving diagnosis, monitoring, and treatment of heart conditions.

  This presentation introduces CardiologIA, a suite of AI-powered tools designed to enhance cardiovascular disease detection and management, developed in partnership with ZeCardioTherapeutics and Hospital de la Santa Creu i Sant Pau. We highlight three innovative projects:

  RAPID-AIM – an AI-driven electrocardiogram (ECG) interpretation tool for faster and more accurate heart attack diagnosis in emergency settings.
  ZeCardio – a deep learning framework leveraging microscopy video analysis of zebrafish larvae to accelerate drug discovery for cardiomyopathies.
  CardioGPT – combining Large-Language models and computer vision for automated and explainable diagnosis of heart motility disorders based on cardiac magnetic resonance imaging (MRI)

  These AI solutions aim to democratize access to high-quality cardiology care, reduce diagnostic errors, and expedite life-saving treatments. By integrating AI into cardiovascular medicine, we can bridge existing disparities, improve patient outcomes, and shape the future of digital healthcare.